Does artificial intelligence and machine learning in health care offer real hope or is all just a lot of hype? That’s the question that Iya Khalil will help answer as part of a panel at the Milken Institute 2018 Global Conference taking place on April 30. The hour-long session will discuss how AI and machine learning can reduce drug discovery times and enable precision medicine with the goal of improving outcomes and reducing the costs of R&D.
The session will be moderated by Rick Berke, Executive Editor at STAT. Other panelists include:
- Rowan Chapman, Head, Johnson and Johnson Innovation California
- Lloyd Minor, Dean, Stanford Medicine
- George Yancopoulos, Chief Scientific Officer, Regeneron
- Megan Zweig, Director of Research, Rock Health
The Milken Institute is a nonprofit, nonpartisan think tank determined to increase global prosperity by advancing collaborative solutions that widen access to capital, create jobs and improve health through independent, data-driven research.